8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
View Webinar On-Demand
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
Join Veristat and IBM Watson Health to learn how they were able to start up their COVID-19 trial in just 5 days and post-go-live protocol amendments in just 3 days.
The discussion will focus on how Veristat used specific IBM Clinical Development features to achieve these results for the rapid start of a COVID-19 trial.
Attend the Complimentary Webinar On-Demand:
Title: Veristat Reduces Study Build Time from Weeks to Days with IBM Clinical Development
Date: Thursday, October 08, 2020 (Original Live Date)
Time: 11:00 AM Eastern Daylight Time
Duration: 45 minutes
(You will be brought to the IBM page to register for the download)
Meet the Speakers:
Ryad RamdaAssociate Director, Data Management
Veristat
Walker Bradham
Offering Manager, IBM Clinical Development
IBM Watson Health
Offering Manager, IBM Clinical Development
IBM Watson Health
Register for the Webinar Now:
(You will be brought to the IBM registration page to download)